Company Analysis

Armata Pharmaceuticals, Inc. (ARMP)

NYSE: ARMP · Biological Products, (No Diagnostic Substances) · Los Angeles, CA · filing with the SEC since 1996
Grade4.7
◀ Past 6.0● Present 4.6▶ Future 3.9
6 est.

Who runs Armata Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Birx Deborah
Chief Executive Officer. First filing Jul 2023, latest Jul 14, 2026, 0 filings in all.
Officers reporting now
3
of 10 people with a filing in the last fifteen months
Directors reporting now
7
30 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Birx DeborahChief Executive OfficerJul 2023Jul 14, 2026none
Kyme PierreChief Business OfficerJun 2024Mar 17, 2026none
House David DuaneSVP, Finance, and PFOAug 2024Mar 11, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Gilmer Daniel B.directorApr 2026Apr 28, 2026none
Haimovitz JulesdirectorApr 2021Mar 11, 2026none
Kramer RobindirectorDec 2020Mar 11, 2026none
Odysseas Kostas DdirectorFeb 2020Mar 11, 2026none
Patti Joseph MdirectorMay 2019Mar 11, 2026none
Peterson Todd C.directorOct 2019Mar 11, 2026none
Schlesinger Sarah J.directorFeb 2020Mar 11, 2026none
Earlier names on the record25, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ARMP · research, not advice